Skip to main content
Log in

Proteomics in atherosclerosis

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

Atherothrombosis is the underlying cause of several clinical manifestations, such as acute coronary syndromes, cerebrovascular disease, and peripheral artery disease, which together are the leading cause of death in the Western world. Proteins from vascular cells or atherosclerotic plaques that are present in plasma are modified along the different steps of atherosclerotic development and constitute target candidates for vascular research, particularly in the search for novel biological markers of cardiovascular risk. In this review, we summarize proteomic techniques and the most recent results obtained by application of these high-throughput strategies to cardiovascular samples.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Blanco-Colio LM, Martín-Ventura JL, Vivanco F, et al.: Biology of atherosclerotic plaques: What we are learning from proteomic analysis. Cardiovasc Res 2006, 72:18–29.

    Article  PubMed  CAS  Google Scholar 

  2. Vivanco F, Mas S, Darde VM, et al.: Vascular proteomics. Proteomics Clin Appl 2007, 1:1102–1122.

    Article  CAS  Google Scholar 

  3. Bagnato C, Thurmar J, Mayya V, et al.: Proteomic analysis of human coronary atherosclerotic plaque. Mol Cell Proteomics 2007, 6:1088–1102.

    Article  PubMed  CAS  Google Scholar 

  4. Wilson AM, Kimura E, Harada RK, et al.: B2-Microglobulin as a biomarker in peripheral arterial disease. Circulation 2007, 116:1396–1403.

    Article  PubMed  CAS  Google Scholar 

  5. Blanco-Colio LM, Martin-Ventura JL, Muñoz-García B, et al.: Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis. Atheroscler Thromb Vasc Biol 2007, 27:916–922.

    Article  CAS  Google Scholar 

  6. Villen J, Beausoleil SA, Gerber SA, Gygi SP: Large-scale phosphorylation analysis of mouse liver. Proc Natl Acad Sci U S A 2007, 104:1488–1493.

    Article  PubMed  CAS  Google Scholar 

  7. Olsen JV, Blangoev B, Gnad F, et al.: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127:635–648.

    Article  PubMed  CAS  Google Scholar 

  8. Duran MC, Boeri-Erba E, Mohammed S, et al.: Characterization of Hsp27 phosphorylation sites in human atherosclerotic plaque secretome. Methods Mol Biol 2007, 357:151–161.

    PubMed  CAS  Google Scholar 

  9. Thingholm TE, Jorgensen TJ, Jensen ON, Laresen MR: Highly selective enrichment of phosphorylated peptides using titanium dioxide. Nat Protocols 2006, 1:1929–1935.

    Article  CAS  Google Scholar 

  10. Mas S, Toubul D, Brunelle A, et al.: Lipid cartography of atherosclerotic plaque by cluster TOF-SIMS Imaging. Analyst 2007, 132:24–26.

    Article  PubMed  CAS  Google Scholar 

  11. Malmberg P, Borner K, Chen Y, et al.: Localization of lipids in the aortic wall with imaging TOF-SIMS. Biochim Biophys Acta 2007, 1771:185–195.

    PubMed  CAS  Google Scholar 

  12. Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res 2006, 47:2101–2111.

    Article  PubMed  CAS  Google Scholar 

  13. Boccardi C, Cecchettini A, Caselli A, et al.: A proteomic approach to the investigation of early events involved in the activation of vascular smooth muscle cells. Cell Tissue Res 2007, 329:119–128.

    Article  PubMed  CAS  Google Scholar 

  14. Dupont A, Pinet F: The proteome and secretome of human arterial smooth muscle cells. Methods Mol Biol 2007, 357:225–233.

    PubMed  CAS  Google Scholar 

  15. Gonzalez-Cabrero J, Pozo M, Duran MC, et al.: The proteome of endothelial cells. Methods Mol Biol 2007, 357:181–198.

    PubMed  CAS  Google Scholar 

  16. Ouwehand WH, Bloodomics and Wellcome Trust Case Control Consortia: Platelet genomics and the risk of atherothromosis. J Thromb Haemost 2007, 5(Suppl 1):188–195.

    Article  PubMed  CAS  Google Scholar 

  17. Hernandez-Ruiz L, Valverde F, Jimenez-Nuñez MD, et al.: Organellar proteomics of human platelet dense granules reveals that 14-3-3zeta is a granule protein related to atherosclerosis. J Proteome Res 2007, 6:4449–4457.

    Article  PubMed  CAS  Google Scholar 

  18. Xu A, Wang Y, Xu JY, et al.: Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 2006, 52:405–413.

    Article  PubMed  CAS  Google Scholar 

  19. Donners MM, Verluyten MJ, Bouwman FG, et al.: Proteomic analysis of differential protein expression in human atherosclerotic plaque progression. J Pathol 2005, 206:39–44.

    Article  PubMed  CAS  Google Scholar 

  20. Sakai J, Ishikawa H, Satoh H, et al.: Two-dimensional difference gel electrophoresis of rat heart proteins in ischemis and ischemia-reperfusion. Methods Mol Biol 2007, 357:33–43.

    PubMed  CAS  Google Scholar 

  21. Martin-Ventura JL, Nicolas V, Houard X, et al.: Biological significance of decreased HSP27 in human atherosclerosis. Atheroscler Thromb Vasc Biol 2006, 26:1337–1343.

    Article  CAS  Google Scholar 

  22. Matt P, Fu Z, Carrel T, et al.: Proteomic alterations in heat shock protein 27 and identification of phosphoproteins in ascending aortic aneurysm associated with bicuspid and tricuspid aortic valve. J Mol Cell Cardiol 2007, 43:792–801.

    Article  PubMed  CAS  Google Scholar 

  23. Righetti PG, Castagna A, Antonioli P, Boschetti E: Prefractionation techniques in proteome analysis: the mining tools of the third millennium. Electrophoresis 2005, 26:297–319.

    Article  PubMed  CAS  Google Scholar 

  24. Alonso-Orgaz S, Moreno L, Macaya C, et al.: Proteomic study of plasma from moderate hypercholesterolemic patients. J Proteome Res 2006, 5:2301–2308.

    Article  PubMed  CAS  Google Scholar 

  25. Lopez-Farre AJ, Mateos-Caceres PJ, Sacristan D, et al.: Relationship between vitamin D binding protein and aspirin resistance in coronary ischemic patients: a proteomic study. J Proteome Res 2007, 6:2481–2487.

    Article  PubMed  CAS  Google Scholar 

  26. Martin-Ventura JL, Blanco-Colio LM, Tuñon J, et al.: Proteomics in atherothrombosis: a future perspective. Expert Rev Proteomics 2007, 4:249–260.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jesus Egido.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Martinez-Pinna, R., Martin-Ventura, J.L., Mas, S. et al. Proteomics in atherosclerosis. Curr Atheroscler Rep 10, 209–215 (2008). https://doi.org/10.1007/s11883-008-0033-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-008-0033-z

Keywords

Navigation